BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3482978)

  • 1. Studies on the possible mechanisms of antitumor action of mouse interferons.
    Belardelli F; Proietti E; Locardi C; Sestili P; Carpinelli G; Di Vito M; Podo F
    Ann Ist Super Sanita; 1987; 23(4):771-5. PubMed ID: 3482978
    [No Abstract]   [Full Text] [Related]  

  • 2. 31P-nuclear magnetic resonance analysis of interferon-induced alterations of phospholipid metabolites in interferon-sensitive and interferon-resistant Friend leukemia cell tumors in mice.
    Proietti E; Carpinelli G; Di Vito M; Belardelli F; Gresser I; Podo F
    Cancer Res; 1986 Jun; 46(6):2849-57. PubMed ID: 2421886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How does interferon inhibit tumor growth?
    Gresser I
    Interferon; 1985; 6():93-126. PubMed ID: 2410371
    [No Abstract]   [Full Text] [Related]  

  • 4. [Interferon effects on the levels of ornithine decarboxylase activity in Friend cells].
    Capobianchi MR; Rossi GB; Dolei A
    Ann Ist Super Sanita; 1982; 18(3):409-11. PubMed ID: 6198945
    [No Abstract]   [Full Text] [Related]  

  • 5. Importance of treatment regimen of interferon as an antitumor agent.
    Lee SH; Chiu H; Rinderknecht E; Sabo W; Stebbing N
    Cancer Res; 1983 Sep; 43(9):4172-5. PubMed ID: 6347366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Increase in the sensitivity of leukemia cells, incubated in interferon, to the effect of immune serum].
    Skurkovich SV; Kalinina IA; Eremkina EI; Bulycheva TI
    Biull Eksp Biol Med; 1976 Dec; 82(12):1459-61. PubMed ID: 1023976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparative quantitative study of the anti-leukemia activity of hexaphosphamide, various anti-leukemia preparations and x-rays].
    Khomchenovskiĭ EI
    Biull Eksp Biol Med; 1968 Apr; 65(4):90-3. PubMed ID: 4991414
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness of mouse interferon alpha/beta compared to single-agent chemotherapy in increasing survival time of mice after intravenous inoculation of Friend erythroleukemia cells.
    Gresser I; Maury C; Belardelli F; Maunoury MT; Machover D
    J Natl Cancer Inst; 1988 Mar; 80(2):126-31. PubMed ID: 3422696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An efficient method for establishing murine tumor cell lines].
    Mi JX
    Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):9-11. PubMed ID: 2364877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. VI. Adjuvant therapy after surgery in the inhibition of liver and spleen metastases.
    Gresser I; Maury C; Belardelli F
    Int J Cancer; 1987 Jun; 39(6):789-92. PubMed ID: 2438237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of action of interferons in the Friend virus-induced leukemia cell system.
    Affabris E; Romeo G; Federico M; Coccia E; Locardi C; Belardelli F; Rossi GB
    Haematologica; 1987; 72(6 Suppl):76-8. PubMed ID: 2450821
    [No Abstract]   [Full Text] [Related]  

  • 12. Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations.
    Fleischmann WR; Kleyn KM; Baron S
    J Natl Cancer Inst; 1980 Nov; 65(5):963-6. PubMed ID: 6159498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of the Friend leukemia virus on lymphocyte subpopulations in the mouse].
    Jezzi T; Premrov MG; Del Gobbo V; Garaci E
    Ann Ist Super Sanita; 1982; 18(3):513-5. PubMed ID: 6230037
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental design for the evaluation of the antitumor action of cytokines.
    Ciolli V; Sestili P; Brigato M; Gabriele L; Varano F; Locardi C; Belardelli F
    Ann Ist Super Sanita; 1990; 26(3-4):441-51. PubMed ID: 2091505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of recombinant adenoviral vectors expressing murine IFN-alpha in mice injected with metastatic IFN-resistant tumor cells.
    Santodonato L; Ferrantini M; Palombo F; Aurisicchio L; Delmastro P; La Monica N; Di Marco S; Ciliberto G; Du MX; Taylor MW; Belardelli F
    Cancer Gene Ther; 2001 Jan; 8(1):63-72. PubMed ID: 11219495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of murine leukemia. V. Protection against Friend leukemia virus-induced immune complex glomerulonephritis by passive serum therapy.
    Sanfilippo F; Genovesi EV; Collins JJ
    J Natl Cancer Inst; 1981 Sep; 67(3):703-17. PubMed ID: 6456369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of a novel nuclear protein (p54) by phorbol esters in mouse erythroleukemia (Friend) cells.
    Mitsuse S; Oishi M
    Cancer Res; 1985 Aug; 45(8):3836-42. PubMed ID: 3860288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of macrophages in suppression of established Friend virus leukemia.
    Levy MH; Wheelock EF
    J Reticuloendothel Soc; 1976 Sep; 20(3):243-54. PubMed ID: 1068297
    [No Abstract]   [Full Text] [Related]  

  • 19. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
    Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F
    Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of established tumor by adoptive immunotherapy with specifically immune T cells.
    Greenberg PD; Cheever MA
    Surv Immunol Res; 1985; 4(4):283-96. PubMed ID: 3879738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.